0001225208-18-001321.txt : 20180119
0001225208-18-001321.hdr.sgml : 20180119
20180119173006
ACCESSION NUMBER: 0001225208-18-001321
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180112
FILED AS OF DATE: 20180119
DATE AS OF CHANGE: 20180119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRADDICK WEIR MIRIAN M
CENTRAL INDEX KEY: 0001168014
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 18538292
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4/A
1
doc4a.xml
X0306
4/A
2018-01-12
2018-01-16
0000310158
Merck & Co., Inc.
MRK
0001168014
GRADDICK WEIR MIRIAN M
MERCK & CO., INC.
2000 GALLOPING HILL ROAD
KENILWORTH
NJ
07033
1
Exe V-P, HR
Common Stock
2018-01-12
4
S
0
8000.0000
58.0000
D
98484.3190
D
Common Stock
2018-01-16
4
M
0
52000.0000
44.3000
A
150484.3190
D
Common Stock
2018-01-16
4
S
0
8000.0000
61.6300
D
142484.3190
D
Common Stock
2018-01-16
4
S
0
52000.0000
61.6300
D
90484.3190
D
The sale reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan.
The original Form 4, filed on January 16, 2018, is being amended by this Form 4 amendment solely to correct an administrative error, which misreported a sale that occurred on January 12, 2018 as a total of 5,000 shares sold when in fact 8,000 shares of the Issuer's common stock were sold. As a result of this administrative error, the number of shares beneficially owned by the reporting person following the corrected transaction reflects a reduction in the number of shares reported as beneficially owned by the reporting person by 3,000 shares, and includes shares acquired in dividend reinvestment transactions.
The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
Faye C. Brown as Attorney-in-Fact for Mirian M. Graddick-Weir
2018-01-19